Page 24 - Screening for Cervical Cancer: Systematic Evidence Review
P. 24

Chapter I.  Introduction



               Analytic Framework and Key Questions



                       The RTI-University of North Carolina Evidence-based Practice Center (RTI-UNC EPC),


               together with members of the USPSTF and other clinical and methodologic experts (see

               Appendix A), sought to update specific topics in the area of cervical cancer screening that have


               evolved rapidly in the past 5 years.  This systematic evidence review (SER) updates Chapter 9

                                                                                  4
               (pages 105-117) of the second Guide to Clinical Preventive Services.



               Analytic Framework


                       Conceptualizing approaches to cervical cancer screening in primary care practice requires


               an analytic framework.  Our framework (Figure 2) is not intended to provide etiologic detail;

               rather, it depicts the relationship between the progression of disease and the potential points of

               intervention to prevent morbidity and mortality.  These potential points of intervention provide


               the rationale for the questions undertaken in this systematic review.

                       The pathway starts with women potentially eligible for screening.  We have


               conceptualized screening as a process that may have more than one component.  For example, a

               woman presenting for care may have her individual risk for cervical cancer assessed based on


               her past sexual history, medical history, and prior Pap test results.  Using that information,

               clinicians determine the need for a Pap test.  If a Pap test is done, the specimen may be prepared


               by conventional methods or new techniques.  The cytology specimen may be read in the

               conventional manner or with pre-screening or re-screening by computer-assisted methods.  Other


               screening studies, such as HPV testing, may be incorporated before a woman is determined to

               have normal or abnormal screening results.








                                                             14
   19   20   21   22   23   24   25   26   27   28   29